Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction

Eric J. Topol, Barry S. George, Dean J. Kereiakes, Richard J. Candela, Charles W. Abbottsmith, David C. Stump, Jane M. Boswick, Richard S. Stack, Robert M. Califf

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Two dosing schedules of intravenous tissue plasminogen activator (t-PA) for acute myocardial infarction were compared in a multicenter trial. At 2.95 ± 1.1 hours from onset of chest pain, 386 patients received 150 mg of intravenous t-PA. For the first 178 patients (group A), 60 mg were given in the first-hour dose and the remaining 90 mg were infused over 7 hours. In the subsequent 208 patients (group B), the first-hour dose was 1.0 mg/kg and the remaining 150 mg were given over 5 hours. At initial angiography 94 ± 30 minutes into therapy, the infarct vessel patency was 64% in group A versus 75% in group B (p = 0.02). By final angiography with up to 4 selective contrast injections, patency was 68% versus 77%, respectively (p = 0.06). Repeat angiography at 7 to 10 days demonstrated reocclusion in 17% of group A and 13% of group B patients (p = 0.35). There was no difference in fibrinogen nadir or mean hematocrit drop between the 2 groups: 120 mg/dl and 11 points, respectively, in group A compared with 120 mg/dl and 10 points in group B. However, bleeding was reduced in group B patients as evident by a decrease in requirement for ≥2 units of packed red blood cell transfusion (group A 36%, group B 27%, p = 0.05) and lower incidence of gastrointestinal bleeding (group A 12%, group B 4%, p = 0.002). To further study the importance of weight adjustment, patients were divided into 2 groups according to weight (≤90 kg versus ≥90 kg). According to the results, lighter weight patients had greater transfusion requirements (35% versus 20%, p = 0.006) and more frequent major bleeding episodes (16% versus 7%, p = 0.025). Thus, a higher, weight-adjusted first-hour dose of intravenous t-PA, with a shorter duration of maintenance infusion, is associated with: (1) improved infarct vessel patency; (2) more rapid recanalization; and (3) less bleeding complications without more fibrinogenolysis.

Original languageEnglish
Pages (from-to)723-728
Number of pages6
JournalThe American journal of cardiology
Volume61
Issue number10
DOIs
StatePublished - Apr 1 1988
Externally publishedYes

Fingerprint

Tissue Plasminogen Activator
Myocardial Infarction
Hemorrhage
Weights and Measures
Angiography
Erythrocyte Transfusion
compound A 12
Chest Pain
Hematocrit
Fibrinogen
Multicenter Studies
Appointments and Schedules
Maintenance
Injections
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Topol, E. J., George, B. S., Kereiakes, D. J., Candela, R. J., Abbottsmith, C. W., Stump, D. C., ... Califf, R. M. (1988). Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction. The American journal of cardiology, 61(10), 723-728. https://doi.org/10.1016/0002-9149(88)91055-7

Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction. / Topol, Eric J.; George, Barry S.; Kereiakes, Dean J.; Candela, Richard J.; Abbottsmith, Charles W.; Stump, David C.; Boswick, Jane M.; Stack, Richard S.; Califf, Robert M.

In: The American journal of cardiology, Vol. 61, No. 10, 01.04.1988, p. 723-728.

Research output: Contribution to journalArticle

Topol, EJ, George, BS, Kereiakes, DJ, Candela, RJ, Abbottsmith, CW, Stump, DC, Boswick, JM, Stack, RS & Califf, RM 1988, 'Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction', The American journal of cardiology, vol. 61, no. 10, pp. 723-728. https://doi.org/10.1016/0002-9149(88)91055-7
Topol, Eric J. ; George, Barry S. ; Kereiakes, Dean J. ; Candela, Richard J. ; Abbottsmith, Charles W. ; Stump, David C. ; Boswick, Jane M. ; Stack, Richard S. ; Califf, Robert M. / Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction. In: The American journal of cardiology. 1988 ; Vol. 61, No. 10. pp. 723-728.
@article{dacf9ec189124e928aa66059f7c3bf76,
title = "Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction",
abstract = "Two dosing schedules of intravenous tissue plasminogen activator (t-PA) for acute myocardial infarction were compared in a multicenter trial. At 2.95 ± 1.1 hours from onset of chest pain, 386 patients received 150 mg of intravenous t-PA. For the first 178 patients (group A), 60 mg were given in the first-hour dose and the remaining 90 mg were infused over 7 hours. In the subsequent 208 patients (group B), the first-hour dose was 1.0 mg/kg and the remaining 150 mg were given over 5 hours. At initial angiography 94 ± 30 minutes into therapy, the infarct vessel patency was 64{\%} in group A versus 75{\%} in group B (p = 0.02). By final angiography with up to 4 selective contrast injections, patency was 68{\%} versus 77{\%}, respectively (p = 0.06). Repeat angiography at 7 to 10 days demonstrated reocclusion in 17{\%} of group A and 13{\%} of group B patients (p = 0.35). There was no difference in fibrinogen nadir or mean hematocrit drop between the 2 groups: 120 mg/dl and 11 points, respectively, in group A compared with 120 mg/dl and 10 points in group B. However, bleeding was reduced in group B patients as evident by a decrease in requirement for ≥2 units of packed red blood cell transfusion (group A 36{\%}, group B 27{\%}, p = 0.05) and lower incidence of gastrointestinal bleeding (group A 12{\%}, group B 4{\%}, p = 0.002). To further study the importance of weight adjustment, patients were divided into 2 groups according to weight (≤90 kg versus ≥90 kg). According to the results, lighter weight patients had greater transfusion requirements (35{\%} versus 20{\%}, p = 0.006) and more frequent major bleeding episodes (16{\%} versus 7{\%}, p = 0.025). Thus, a higher, weight-adjusted first-hour dose of intravenous t-PA, with a shorter duration of maintenance infusion, is associated with: (1) improved infarct vessel patency; (2) more rapid recanalization; and (3) less bleeding complications without more fibrinogenolysis.",
author = "Topol, {Eric J.} and George, {Barry S.} and Kereiakes, {Dean J.} and Candela, {Richard J.} and Abbottsmith, {Charles W.} and Stump, {David C.} and Boswick, {Jane M.} and Stack, {Richard S.} and Califf, {Robert M.}",
year = "1988",
month = "4",
day = "1",
doi = "10.1016/0002-9149(88)91055-7",
language = "English",
volume = "61",
pages = "723--728",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction

AU - Topol, Eric J.

AU - George, Barry S.

AU - Kereiakes, Dean J.

AU - Candela, Richard J.

AU - Abbottsmith, Charles W.

AU - Stump, David C.

AU - Boswick, Jane M.

AU - Stack, Richard S.

AU - Califf, Robert M.

PY - 1988/4/1

Y1 - 1988/4/1

N2 - Two dosing schedules of intravenous tissue plasminogen activator (t-PA) for acute myocardial infarction were compared in a multicenter trial. At 2.95 ± 1.1 hours from onset of chest pain, 386 patients received 150 mg of intravenous t-PA. For the first 178 patients (group A), 60 mg were given in the first-hour dose and the remaining 90 mg were infused over 7 hours. In the subsequent 208 patients (group B), the first-hour dose was 1.0 mg/kg and the remaining 150 mg were given over 5 hours. At initial angiography 94 ± 30 minutes into therapy, the infarct vessel patency was 64% in group A versus 75% in group B (p = 0.02). By final angiography with up to 4 selective contrast injections, patency was 68% versus 77%, respectively (p = 0.06). Repeat angiography at 7 to 10 days demonstrated reocclusion in 17% of group A and 13% of group B patients (p = 0.35). There was no difference in fibrinogen nadir or mean hematocrit drop between the 2 groups: 120 mg/dl and 11 points, respectively, in group A compared with 120 mg/dl and 10 points in group B. However, bleeding was reduced in group B patients as evident by a decrease in requirement for ≥2 units of packed red blood cell transfusion (group A 36%, group B 27%, p = 0.05) and lower incidence of gastrointestinal bleeding (group A 12%, group B 4%, p = 0.002). To further study the importance of weight adjustment, patients were divided into 2 groups according to weight (≤90 kg versus ≥90 kg). According to the results, lighter weight patients had greater transfusion requirements (35% versus 20%, p = 0.006) and more frequent major bleeding episodes (16% versus 7%, p = 0.025). Thus, a higher, weight-adjusted first-hour dose of intravenous t-PA, with a shorter duration of maintenance infusion, is associated with: (1) improved infarct vessel patency; (2) more rapid recanalization; and (3) less bleeding complications without more fibrinogenolysis.

AB - Two dosing schedules of intravenous tissue plasminogen activator (t-PA) for acute myocardial infarction were compared in a multicenter trial. At 2.95 ± 1.1 hours from onset of chest pain, 386 patients received 150 mg of intravenous t-PA. For the first 178 patients (group A), 60 mg were given in the first-hour dose and the remaining 90 mg were infused over 7 hours. In the subsequent 208 patients (group B), the first-hour dose was 1.0 mg/kg and the remaining 150 mg were given over 5 hours. At initial angiography 94 ± 30 minutes into therapy, the infarct vessel patency was 64% in group A versus 75% in group B (p = 0.02). By final angiography with up to 4 selective contrast injections, patency was 68% versus 77%, respectively (p = 0.06). Repeat angiography at 7 to 10 days demonstrated reocclusion in 17% of group A and 13% of group B patients (p = 0.35). There was no difference in fibrinogen nadir or mean hematocrit drop between the 2 groups: 120 mg/dl and 11 points, respectively, in group A compared with 120 mg/dl and 10 points in group B. However, bleeding was reduced in group B patients as evident by a decrease in requirement for ≥2 units of packed red blood cell transfusion (group A 36%, group B 27%, p = 0.05) and lower incidence of gastrointestinal bleeding (group A 12%, group B 4%, p = 0.002). To further study the importance of weight adjustment, patients were divided into 2 groups according to weight (≤90 kg versus ≥90 kg). According to the results, lighter weight patients had greater transfusion requirements (35% versus 20%, p = 0.006) and more frequent major bleeding episodes (16% versus 7%, p = 0.025). Thus, a higher, weight-adjusted first-hour dose of intravenous t-PA, with a shorter duration of maintenance infusion, is associated with: (1) improved infarct vessel patency; (2) more rapid recanalization; and (3) less bleeding complications without more fibrinogenolysis.

UR - http://www.scopus.com/inward/record.url?scp=0023852670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023852670&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(88)91055-7

DO - 10.1016/0002-9149(88)91055-7

M3 - Article

VL - 61

SP - 723

EP - 728

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10

ER -